Search keyWord :

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

Feb 14, 2025

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Schwab Makes Expanded 24-Hour Trading Available to All Clients

Feb 14, 2025

Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite

Webull Masters 2025 Kicks Off: an Exciting Stock Trading Competition in Thailand with Over THB170,000 in Prizes

Feb 14, 2025

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

Feb 14, 2025

This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights

Happy Chinese New Year 2025: Jiangsu's Intangible Cultural Heritage Takes the Global Spotlight

Feb 14, 2025

NANJING,China,Feb. 13,2025-- On December 4th,2024,UNESCO inscribed the "Spring Festival,Social Practices of the Chinese People in Celebration of Traditional New Year" on its Representative L

Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management

Feb 14, 2025

KAWASAKI,Japan,Feb. 13,2025-- Fujitsu today announced the launch of theFujitsu Cloud Service Generative AI Platform. The new service,which combines data confidentiality with the ease of use of the clo

Databricks Announces Launch of SAP Databricks

Feb 14, 2025

Databricks announces new product natively integrated into the SAP Business Data Cloud SAN FRANCISCO,Feb. 13,2025--Databricks,the Data and AI company,today announced the launch of SAP Databricks,a str

Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium

Feb 14, 2025

CHENGDU,China,Feb. 13,2025-- At the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium 2025,to be held in San Francisco,USA,from Feb. 13-15,2025,Sichuan Kelun-Biotech Bi

The 137th Canton Fair Hosts Promotion Events in Southeast Asia, Bridging Trade and International Exchanges

Feb 14, 2025

GUANGZHOU,China,Feb. 13,2025-- As China\'s No.1 platform for international trade,the 137th Canton Fair has successfully hosted a Southeast Asiaroadshow with trade promotion events in Vietnam,Laos and

Bad Data Makes Bad Decisions: 65% of Asia-Pacific Leaders Report Companies Using Inaccurate Data for Big Decisions

Feb 14, 2025

On average,APAC leaders are struggling more with data management issues compared to North America/EMEA counterparts,according to global study from SoftServe

1 ... 332 333 334 335 336 337 338 ... 1257